Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

BRSL vs SRAD vs DKNG vs GENI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
BRSL
Brightstar Lottery

Gambling, Resorts & Casinos

Consumer CyclicalNYSE • GB
Market Cap$2.35B
5Y Perf.-50.4%
SRAD
Sportradar Group AG

Software - Application

TechnologyNASDAQ • CH
Market Cap$4.04B
5Y Perf.-42.4%
DKNG
DraftKings Inc.

Gambling, Resorts & Casinos

Consumer CyclicalNASDAQ • US
Market Cap$12.50B
5Y Perf.-47.0%
GENI
Genius Sports Limited

Internet Content & Information

Communication ServicesNYSE • GB
Market Cap$1.17B
5Y Perf.-76.4%

BRSL vs SRAD vs DKNG vs GENI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
BRSL logoBRSL
SRAD logoSRAD
DKNG logoDKNG
GENI logoGENI
IndustryGambling, Resorts & CasinosSoftware - ApplicationGambling, Resorts & CasinosInternet Content & Information
Market Cap$2.35B$4.04B$12.50B$1.17B
Revenue (TTM)$2.51B$1.33B$6.05B$669M
Net Income (TTM)$147M$70M$4M$-112M
Gross Margin47.1%38.2%41.3%22.9%
Operating Margin29.8%9.3%-0.2%-18.1%
Forward P/E15.1x32.4x104.4x161.2x
Total Debt$4.25B$63M$1.93B$30M
Cash & Equiv.$1.45B$365M$1.60B$281M

BRSL vs SRAD vs DKNG vs GENILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

BRSL
SRAD
DKNG
GENI
StockSep 21May 26Return
Brightstar Lottery (BRSL)10049.6-50.4%
Sportradar Group AG (SRAD)10057.6-42.4%
DraftKings Inc. (DKNG)10053.0-47.0%
Genius Sports Limit… (GENI)10023.6-76.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: BRSL vs SRAD vs DKNG vs GENI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: BRSL leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Sportradar Group AG is the stronger pick specifically for capital preservation and lower volatility and operational efficiency and capital deployment. GENI also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
BRSL
Brightstar Lottery
The Income Pick

BRSL carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 2 yrs, beta 0.91, yield 30.8%
  • 31.3% 10Y total return vs DKNG's 157.3%
  • Lower P/E (15.1x vs 161.2x)
  • 5.9% margin vs GENI's -16.7%
Best for: income & stability and long-term compounding
SRAD
Sportradar Group AG
The Defensive Pick

SRAD is the #2 pick in this set and the best alternative if sleep-well-at-night and defensive is your priority.

  • Lower volatility, beta 0.65, Low D/E 6.4%, current ratio 1.17x
  • Beta 0.65, current ratio 1.17x
  • Beta 0.65 vs GENI's 1.50
  • 2.7% ROA vs GENI's -11.1%, ROIC 12.9% vs -16.6%
Best for: sleep-well-at-night and defensive
DKNG
DraftKings Inc.
The Growth Play

DKNG is the clearest fit if your priority is growth exposure.

  • Rev growth 27.0%, EPS growth 99.2%, 3Y rev CAGR 39.3%
Best for: growth exposure
GENI
Genius Sports Limited
The Growth Leader

GENI is the clearest fit if your priority is growth.

  • 31.0% revenue growth vs BRSL's -0.0%
Best for: growth
See the full category breakdown
CategoryWinnerWhy
GrowthGENI logoGENI31.0% revenue growth vs BRSL's -0.0%
ValueBRSL logoBRSLLower P/E (15.1x vs 161.2x)
Quality / MarginsBRSL logoBRSL5.9% margin vs GENI's -16.7%
Stability / SafetySRAD logoSRADBeta 0.65 vs GENI's 1.50
DividendsBRSL logoBRSL30.8% yield; 2-year raise streak; the other 3 pay no meaningful dividend
Momentum (1Y)BRSL logoBRSL-2.4% vs GENI's -53.1%
Efficiency (ROA)SRAD logoSRAD2.7% ROA vs GENI's -11.1%, ROIC 12.9% vs -16.6%

BRSL vs SRAD vs DKNG vs GENI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

BRSLBrightstar Lottery

Segment breakdown not available.

SRADSportradar Group AG
FY 2023
Betting data / Betting entertainment tools
46.6%$278M
Managed Betting Services ("MBS")
29.5%$176M
Other revenue
9.3%$55M
Betting revenue
8.5%$51M
Sports Solutions
6.2%$37M
DKNGDraftKings Inc.
FY 2025
Product and Service, Other
100.0%$423M
GENIGenius Sports Limited
FY 2025
Betting Technology Content And Services
70.4%$472M
Media Technology Content And Services
21.6%$144M
Sports Technology And Services
8.0%$53M

BRSL vs SRAD vs DKNG vs GENI — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLBRSLLAGGINGGENI

Income & Cash Flow (Last 12 Months)

BRSL leads this category, winning 3 of 6 comparable metrics.

DKNG is the larger business by revenue, generating $6.1B annually — 9.0x GENI's $669M. BRSL is the more profitable business, keeping 5.9% of every revenue dollar as net income compared to GENI's -16.7%. On growth, DKNG holds the edge at +42.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricBRSL logoBRSLBrightstar LotterySRAD logoSRADSportradar Group …DKNG logoDKNGDraftKings Inc.GENI logoGENIGenius Sports Lim…
RevenueTrailing 12 months$2.5B$1.3B$6.1B$669M
EBITDAEarnings before interest/tax$1.1B$308M$266M-$50M
Net IncomeAfter-tax profit$147M$70M$4M-$112M
Free Cash FlowCash after capex-$456M$363M$612M$37M
Gross MarginGross profit ÷ Revenue+47.1%+38.2%+41.3%+22.9%
Operating MarginEBIT ÷ Revenue+29.8%+9.3%-0.2%-18.1%
Net MarginNet income ÷ Revenue+5.9%+5.2%+0.1%-16.7%
FCF MarginFCF ÷ Revenue-18.2%+27.3%+10.1%+5.5%
Rev. Growth (YoY)Latest quarter vs prior year+2.5%+13.2%+42.8%+37.0%
EPS Growth (YoY)Latest quarter vs prior year-70.1%-128.5%+192.9%+33.8%
BRSL leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

BRSL leads this category, winning 4 of 6 comparable metrics.

On an enterprise value basis, BRSL's 4.7x EV/EBITDA is more attractive than DKNG's 49.4x.

MetricBRSL logoBRSLBrightstar LotterySRAD logoSRADSportradar Group …DKNG logoDKNGDraftKings Inc.GENI logoGENIGenius Sports Lim…
Market CapShares × price$2.3B$4.0B$12.5B$1.2B
Enterprise ValueMkt cap + debt − cash$5.2B$3.7B$12.8B$924M
Trailing P/EPrice ÷ TTM EPS-1269.00x38.69x-3113.58x-10.83x
Forward P/EPrice ÷ next-FY EPS est.15.07x32.39x104.42x161.17x
PEG RatioP/E ÷ EPS growth rate0.68x
EV / EBITDAEnterprise value multiple4.67x17.74x49.42x
Price / SalesMarket cap ÷ Revenue0.94x2.77x2.06x1.75x
Price / BookPrice ÷ Book value/share1.57x3.79x19.81x1.68x
Price / FCFMarket cap ÷ FCF8.98x19.31x18.18x
BRSL leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

Evenly matched — BRSL and SRAD each lead in 3 of 9 comparable metrics.

BRSL delivers a 9.2% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-16 for GENI. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DKNG's 3.06x. On the Piotroski fundamental quality scale (0–9), DKNG scores 7/9 vs GENI's 3/9, reflecting strong financial health.

MetricBRSL logoBRSLBrightstar LotterySRAD logoSRADSportradar Group …DKNG logoDKNGDraftKings Inc.GENI logoGENIGenius Sports Lim…
ROE (TTM)Return on equity+9.2%+7.3%+0.5%-15.5%
ROA (TTM)Return on assets+1.6%+2.7%+0.1%-11.1%
ROICReturn on invested capital+11.7%+12.9%-0.9%-16.6%
ROCEReturn on capital employed+12.9%+5.3%-0.6%-15.3%
Piotroski ScoreFundamental quality 0–94473
Debt / EquityFinancial leverage2.67x0.06x3.06x0.04x
Net DebtTotal debt minus cash$2.8B-$302M$330M-$250M
Cash & Equiv.Liquid assets$1.4B$365M$1.6B$281M
Total DebtShort + long-term debt$4.3B$63M$1.9B$30M
Interest CoverageEBIT ÷ Interest expense3.66x2.02x1.92x-136.57x
Evenly matched — BRSL and SRAD each lead in 3 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

BRSL leads this category, winning 3 of 6 comparable metrics.

A $10,000 investment in BRSL five years ago would be worth $10,703 today (with dividends reinvested), compared to $2,536 for GENI. Over the past 12 months, BRSL leads with a -2.4% total return vs GENI's -53.1%. The 3-year compound annual growth rate (CAGR) favors GENI at 5.5% vs BRSL's -12.8% — a key indicator of consistent wealth creation.

MetricBRSL logoBRSLBrightstar LotterySRAD logoSRADSportradar Group …DKNG logoDKNGDraftKings Inc.GENI logoGENIGenius Sports Lim…
YTD ReturnYear-to-date-15.6%-41.5%-29.3%-55.8%
1-Year ReturnPast 12 months-2.4%-41.4%-27.3%-53.1%
3-Year ReturnCumulative with dividends-33.8%+5.7%+4.3%+17.4%
5-Year ReturnCumulative with dividends+7.0%-45.5%-47.9%-74.6%
10-Year ReturnCumulative with dividends+31.3%-45.5%+157.3%-52.4%
CAGR (3Y)Annualised 3-year return-12.8%+1.9%+1.4%+5.5%
BRSL leads this category, winning 3 of 6 comparable metrics.

Risk & Volatility

Evenly matched — BRSL and SRAD each lead in 1 of 2 comparable metrics.

SRAD is the less volatile stock with a 0.65 beta — it tends to amplify market swings less than GENI's 1.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BRSL currently trades 68.3% from its 52-week high vs GENI's 34.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricBRSL logoBRSLBrightstar LotterySRAD logoSRADSportradar Group …DKNG logoDKNGDraftKings Inc.GENI logoGENIGenius Sports Lim…
Beta (5Y)Sensitivity to S&P 5000.93x0.63x1.06x1.39x
52-Week HighHighest price in past year$18.57$32.22$48.78$13.73
52-Week LowLowest price in past year$12.02$11.66$20.46$3.83
% of 52W HighCurrent price vs 52-week peak+68.3%+42.3%+51.7%+34.7%
RSI (14)Momentum oscillator 0–10047.138.755.145.3
Avg Volume (50D)Average daily shares traded1.1M3.6M12.9M5.6M
Evenly matched — BRSL and SRAD each lead in 1 of 2 comparable metrics.

Analyst Outlook

BRSL leads this category, winning 1 of 1 comparable metric.

Analyst consensus: BRSL as "Buy", SRAD as "Buy", DKNG as "Buy", GENI as "Buy". Consensus price targets imply 134.4% upside for GENI (target: $11) vs 45.3% for DKNG (target: $37). BRSL is the only dividend payer here at 30.80% yield — a key consideration for income-focused portfolios.

MetricBRSL logoBRSLBrightstar LotterySRAD logoSRADSportradar Group …DKNG logoDKNGDraftKings Inc.GENI logoGENIGenius Sports Lim…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$18.50$20.85$36.64$11.17
# AnalystsCovering analysts6204819
Dividend YieldAnnual dividend ÷ price+30.8%
Dividend StreakConsecutive years of raises21
Dividend / ShareAnnual DPS$3.91
Buyback YieldShare repurchases ÷ mkt cap+11.5%+2.9%+6.6%0.0%
BRSL leads this category, winning 1 of 1 comparable metric.
Key Takeaway

BRSL leads in 4 of 6 categories — strongest in Income & Cash Flow and Valuation Metrics. 2 categories are tied.

Best OverallBrightstar Lottery (BRSL)Leads 4 of 6 categories
Loading custom metrics...

BRSL vs SRAD vs DKNG vs GENI: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is BRSL or SRAD or DKNG or GENI a better buy right now?

For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.

0% revenue growth year-over-year, versus -0. 0% for Brightstar Lottery (BRSL). Sportradar Group AG (SRAD) offers the better valuation at 38. 7x trailing P/E (32. 4x forward), making it the more compelling value choice. Analysts rate Brightstar Lottery (BRSL) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — BRSL or SRAD or DKNG or GENI?

On forward P/E, Brightstar Lottery is actually cheaper at 15.

1x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — BRSL or SRAD or DKNG or GENI?

Over the past 5 years, Brightstar Lottery (BRSL) delivered a total return of +7.

0%, compared to -74. 6% for Genius Sports Limited (GENI). Over 10 years, the gap is even starker: DKNG returned +160. 4% versus GENI's -56. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — BRSL or SRAD or DKNG or GENI?

By beta (market sensitivity over 5 years), Sportradar Group AG (SRAD) is the lower-risk stock at 0.

63β versus Genius Sports Limited's 1. 39β — meaning GENI is approximately 120% more volatile than SRAD relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 3% for DraftKings Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — BRSL or SRAD or DKNG or GENI?

By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.

0% versus -0. 0% for Brightstar Lottery (BRSL). On earnings-per-share growth, the picture is similar: Sportradar Group AG grew EPS 200. 0% year-over-year, compared to -100. 5% for Brightstar Lottery. Over a 3-year CAGR, DKNG leads at 39. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — BRSL or SRAD or DKNG or GENI?

Sportradar Group AG (SRAD) is the more profitable company, earning 7.

8% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 7. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BRSL leads at 35. 1% versus -15. 6% for GENI. At the gross margin level — before operating expenses — BRSL leads at 41. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is BRSL or SRAD or DKNG or GENI more undervalued right now?

On forward earnings alone, Brightstar Lottery (BRSL) trades at 15.

1x forward P/E versus 161. 2x for Genius Sports Limited — 146. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GENI: 134. 4% to $11. 17.

08

Which pays a better dividend — BRSL or SRAD or DKNG or GENI?

In this comparison, BRSL (30.

8% yield) pays a dividend. SRAD, DKNG, GENI do not pay a meaningful dividend and should not be held primarily for income.

09

Is BRSL or SRAD or DKNG or GENI better for a retirement portfolio?

For long-horizon retirement investors, Brightstar Lottery (BRSL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

93), 30. 8% yield). Both have compounded well over 10 years (BRSL: +33. 4%, GENI: -56. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between BRSL and SRAD and DKNG and GENI?

These companies operate in different sectors (BRSL (Consumer Cyclical) and SRAD (Technology) and DKNG (Consumer Cyclical) and GENI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BRSL is a small-cap income-oriented stock; SRAD is a small-cap quality compounder stock; DKNG is a mid-cap high-growth stock; GENI is a small-cap high-growth stock. BRSL pays a dividend while SRAD, DKNG, GENI do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

BRSL

Income & Dividend Stock

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 12.3%
Run This Screen
Stocks Like

SRAD

Quality Business

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Net Margin > 5%
Run This Screen
Stocks Like

DKNG

High-Growth Disruptor

  • Sector: Consumer Cyclical
  • Market Cap > $100B
  • Revenue Growth > 21%
  • Gross Margin > 24%
Run This Screen
Stocks Like

GENI

High-Growth Disruptor

  • Sector: Communication Services
  • Market Cap > $100B
  • Revenue Growth > 18%
  • Gross Margin > 13%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform BRSL and SRAD and DKNG and GENI on the metrics below

Revenue Growth>
%
(BRSL: 2.5% · SRAD: 13.2%)
Net Margin>
%
(BRSL: 5.9% · SRAD: 5.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.